16P11.2 Deletion Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which 16P11.2 Deletion Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01238250

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders a…

United States100,000 participantsStarted 2010-10

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT04271332

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

This Phase 2 study examines the safety, tolerability, and efficacy of arbaclofen in pediatric subjects with 16p11.2 deletion. Male or female subjects aged 5 to…

United States60 participantsStarted 2022-09-01

Treatment: Arbaclofen, Placebo oral tablet